Faecal immunochemical test-based prediction tools

Topic Status Complete

Faecal immunochemical test-based prediction tools for the assessment of people presenting to primary care with symptomatic bowel disease.

Outcome of the appraisal

 

The evidence supports the adoption of FIT to guide the referral of patients with lower gastrointestinal symptoms for colonoscopy. The use of the FIT-based prediction tools FAST and COLONPREDICT shows promise but the incremental benefits as compared with FIT alone are uncertain from the evidence currently available.

HTW therefore supports the adoption of FIT as recommended by NICE Diagnostic Guidance 30 but proposes that a prospective and structured evaluation of the clinical and cost benefits of combining FIT with the prediction tools FAST and COLONPREDICT be incorporated into the implementation strategy in NHS Wales.

Why was this topic appraised?

 

The majority of colorectal cancer cases are diagnosed through GP referral. NICE Diagnostics Guidance 30 recommends faecal immunochemical tests (FITs) to guide referral of symptomatic patients in primary care who do not meet the referral criteria for suspected cancer referral (NICE guideline 12). FIT-based prediction tools could help optimise referral for colorectal cancer investigations, reducing unnecessary colonoscopies.

Topic Exploration Report

TER011 (08.2018)

TER
View PDF

Evidence Appraisal Review

EAR007 (01.2018)

EAR
View PDF

Guidance


GUI007 (02.2018)

GUI
View PDF

Access our guidance

Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.
  • We may like to contact you by email to find out more about how you used the documents.

  • This field is for validation purposes and should be left unchanged.